WOLVERINE ASSET MANAGEMENT LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$3,242,000
+1066.2%
853,416
+1458.2%
0.05%
+1466.7%
Q4 2019$278,000
+28.1%
54,769
+43.7%
0.00%
-40.0%
Q3 2015$217,000
-78.1%
38,108
-71.1%
0.01%
-77.3%
Q2 2015$991,000
-0.4%
131,644
-14.1%
0.02%
+10.0%
Q1 2015$995,000
+107.3%
153,238
+145.1%
0.02%
+122.2%
Q4 2014$480,000
-46.1%
62,530
-61.9%
0.01%
-52.6%
Q3 2014$891,000
-13.4%
164,066
-31.2%
0.02%
-13.6%
Q2 2014$1,029,000
+32.9%
238,437
+26.8%
0.02%
+37.5%
Q1 2014$774,000
+5853.8%
188,064
+95364.0%
0.02%
Q4 2013$13,000
+550.0%
197
+535.5%
0.00%
Q3 2013$2,000310.00%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q2 2020.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders